Dupixent comes in a prefilled syringe or prefilled pen for injection under the skin ... Albuterol (ProAir HFA, Ventolin HFA) is an example of a rescue inhaler. Dupixent is used to treat ...

For example, 15 kg is about 33 lb ... Can I switch from using the Dupixent prefilled syringe to the prefilled pen? Will my Dupixent dosage change if it’s not helping my condition?

Dupixent has interactions with some other drugs. Examples include certain seizure medications, warfarin, and certain heart medications. Dupixent is prescribed for the following conditions in ...

For people with COPD, Dupixent is given via subcutaneous injections, at a recommended dose of 300 mg, once every other week. It is available as a single-dose prefilled syringe or prefilled pen ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by ...

The US Food and Drug Administration (FDA) has accepted for review the resubmitted supplemental Biologics License Application (sBLA) for Sanofi and Regeneron’s Dupixent (dupilumab) in chronic ...

(REGN) announced Friday that the U.S. Food and Drug Administration has accepted for review the resubmission of the supplemental biologics license application or sBLA for Dupixent (dupilumab ...

Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chronic obstructive ...

The BOREAS Phase III trial showed DUPIXENT reduced exacerbations by 30% and improved lung function by 160 mL at 52 weeks. Approximately 44 million COPD cases were recorded in 2023 in the 7MM ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic spontaneous urticaria, an inflammatory skin disease. The FDA has accepted the ...

FDA decision expected by April 18, 2025; if approved, Dupixent would be the first targeted therapy for CSU in a decade TARRYTOWN, N.Y. and PARIS, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Regeneron ...

This makes the new indication for Dupixent very important for Sanofi as it searches for a blockbuster to transform its fortunes. The FDA is set to make a decision on Dupixent’s new indication on ...